Drugs with this side effect as MedDRA Preferred Term
- 4-methylpyrazole
- 5-ASA
- Vision blurred: postmarketing
- 5-FU
- 5-aza-2'-deoxycytidine
- Vision blurred: 0% - 6.02%
- A77 1726
- Vision blurred: 2.79% - 3%
- Anidulafungin
- Azarga
- BCNU
- Benicar-HCT
- CAS 76095-16-4
- CAS 76420-72-9
- Vision blurred: postmarketing
- CGP 19835A
- Cancidas
- Cantril
- FTY720
- Vision blurred: common, 4%
- Ge-132
- Vision blurred: postmarketing
- Goserelin
- Insulin
- K779
- L-Dmp
- LY146032
- Leuprorelin
- LiOH
- Lisinopril
- Vision blurred: 0.3% - 1.1%
- MK-462
- N-methylscopolamine
- Octreotide
- Optison
- Vision blurred: postmarketing
- PCI-32765
- PGE2
- Prednefrin
- Sativex
- SonoVue
- Stalevo 50
- Supremon
- TR-700
- TlCl
- Triptorelin
- acebutolol
- acetaminophen
- acitretin
- Vision blurred: postmarketing, 1- 10%
- aclidinium bromide
- adenosine
- agomelatine
- alfentanil
- almotriptan
- Vision blurred: postmarketing
- alprazolam
- Vision blurred: frequent, 0.4% - 21.4%
- amantadine
- Vision blurred: uncommon, common
- amiodarone
- amitriptyline
- amoxapine
- amsacrine
- anagrelide
- apraclonidine
- Vision blurred: postmarketing
- aripiprazole
- Vision blurred: common, 1% - 8%
- arsenic
- arsenic trioxide
- atenolol
- Vision blurred: postmarketing
- atomoxetine
- atorvastatin
- atropine
- avanafil
- azelastine
- Vision blurred: postmarketing
- azithromycin
- baclofen
- Vision blurred: common, 0% - 5%
- bazedoxifene
- benzathine penicillin
- benztropine
- bepridil
- besifloxacin
- betaxolol
- Vision blurred: postmarketing
- bimatoprost
- Vision blurred: postmarketing, common
- boceprevir
- bortezomib
- bosentan
- brimonidine
- brinzolamide
- Vision blurred: postmarketing, 1.3% - 5.4%
- bromazepam
- Vision blurred: postmarketing
- bromfenac
- bromocriptine
- Vision blurred: postmarketing, rare
- budesonide
- bupivacaine
- buprenorphine
- bupropion
- Vision blurred: postmarketing, frequent, 2% - 14.6%
- buspirone
- Vision blurred: frequent, 2% - 6%
- butorphanol
- cabozantinib
- candesartan cilexetil
- capecitabine
- captopril
- carbamazepine
- Vision blurred: common, 6%
- carbidopa
- carbinoxamine
- carboplatin
- carboprost
- carteolol
- carvedilol
- Vision blurred: 0.2% - 2.8%
- ceftazidime
- celecoxib
- cerivastatin
- cetirizine
- Vision blurred: postmarketing
- chloroprocaine
- chloroquine
- chlorpheniramine
- ciprofloxacin
- Vision blurred: postmarketing, uncommon
- cisplatin
- citalopram
- Vision blurred: infrequent, uncommon, frequent
- clemastine
- clobazam
- Vision blurred: postmarketing
- clobetasol
- Vision blurred: postmarketing
- clomiphene citrate
- clomipramine
- Vision blurred: very common
- clonazepam
- clonidine
- clorazepate
- clozapine
- Vision blurred: postmarketing
- crizotinib
- cyclizine
- cyclobenzaprine
- cyclopentolate
- cyclophosphamide
- cyproheptadine
- cytarabine
- Vision blurred: 11% - 14.3%
- cytokinin
- dabrafenib
- dacarbazine
- danazol
- dantrolene
- Vision blurred: 3.23% - 3.33%
- dapsone
- darifenacin
- dasatinib
- deferoxamine
- degarelix
- delavirdine
- deprenyl
- desipramine
- desvenlafaxine
- diazepam
- diazoxide
- diclofenac
- Vision blurred: very rare, postmarketing
- dicyclomine
- Vision blurred: postmarketing, 27%
- diethylpropion
- diflunisal
- digoxin
- diltiazem
- dimenhydrinate
- diphenhydramine
- disopyramide
- donepezil
- dorzolamide
- dothiepin
- doxazosin
- Vision blurred: postmarketing
- doxepin
- Vision blurred: infrequent
- doxorubicin
- duloxetine
- Vision blurred: postmarketing, frequent, 2% - 3%
- echothiophate
- efavirenz
- Vision blurred: postmarketing, uncommon
- emedastine
- epitopic
- eslicarbazepine
- eslicarbazepine acetate
- esomeprazole magnesium
- Vision blurred: postmarketing
- ethacrynic acid
- ethambutol
- ethionamide
- etodolac
- etoricoxib
- Vision blurred: postmarketing
- etravirine
- everolimus
- febuxostat
- fenoprofen
- fentanyl
- Vision blurred: postmarketing
- ferumoxytol
- Vision blurred: postmarketing
- fesoterodine
- Vision blurred: postmarketing
- fexofenadine
- flavoxate
- flecainide
- flumazenil
- flunisolide
- fluocinolone acetonide
- fluorometholone
- Vision blurred: postmarketing
- fluphenazine
- fluphenazine decanoate
- flurazepam
- fluticasone
- Vision blurred: postmarketing
- fluticasone propionate
- Vision blurred: postmarketing
- fluvoxamine
- Vision blurred: postmarketing
- fosinopril
- furosemide
- fusidic acid
- gabapentin
- Vision blurred: 2% - 5%
- Difficulty focusing eyes: rare
- gadoversetamide
- galantamine
- Vision blurred: postmarketing
- ganciclovir
- gatifloxacin
- gemfibrozil
- glibenclamide
- glimepiride
- glipizide
- glycine
- glycopyrrolate
- guanfacine
- Vision blurred: postmarketing
- haloperidol
- homatropine
- hydrochlorothiazide
- hydromorphone
- hydroxybutyrate
- Vision blurred: postmarketing
- hydroxychloroquine
- hydroxypropyl
- ibuprofen
- icodextrin
- Vision blurred: postmarketing
- ifosfamide
- Vision blurred: postmarketing
- iloperidone
- imatinib
- Vision blurred: common, 0% - 11.1%
- imipramine
- indapamide
- indinavir
- indomethacin
- iopromide
- ioversol
- ipratropium bromide
- irbesartan
- irbesartan-hydrochlorothiazide
- isoproterenol
- isosorbide-5-mononitrate
- isradipine
- itraconazole
- Vision blurred: postmarketing
- ivabradine
- ketamine
- ketorolac
- ketorolac tromethamine
- labetalol
- lacosamide
- lamotrigine
- lansoprazole
- Vision blurred: postmarketing
- latanoprost
- Vision blurred: 1.1% - 2%
- leflunomide
- lenalidomide
- Vision blurred: postmarketing, 17.3%
- lercanidipine
- Vision blurred: very common
- letrozole
- Vision blurred: postmarketing
- leuprorelin acetate
- levetiracetam
- levodopa/carbidopa
- lidocaine
- linezolid
- lisdexamfetamine dimesylate
- Vision blurred: postmarketing
- lithium
- lithium carbonate
- lodoxamide
- lodoxamide tromethamine
- lorazepam
- lorcaserin
- losartan
- loteprednol etabonate
- lovastatin
- Vision blurred: 0.9% - 1.2%
- loxapine
- lurasidone
- lymecycline
- malvidin
- Vision blurred: 2.6% - 18%
- mannitol
- maprotiline
- mecamylamine
- meclofenamate
- Vision blurred: postmarketing
- medrysone
- mefenamic acid
- mefloquine
- Vision blurred: postmarketing
- melatonin
- meloxicam
- Vision blurred: postmarketing
- memantine
- Vision blurred: infrequent
- mepivacaine
- metaproterenol
- Vision blurred: 0.2% - 1%
- metformin
- methocarbamol
- methotrexate
- methsuximide
- methyclothiazide
- methylphenidate
- Vision blurred: postmarketing, rare, 1.3% - 1.7%
- metipranolol
- metolazone
- metoprolol
- Vision blurred: postmarketing
- metronidazole
- mexiletine
- Vision blurred: 2% - 7.5%
- midazolam
- Vision blurred
- Difficulty focusing eyes
- milnacipran
- minocycline
- mirabegron
- mitomycin C
- mitotane
- mitoxantrone
- moclobemide
- molindone
- monamine
- morphine
- moxifloxacin
- mycophenolic acid
- nabilone
- nadolol
- nalbuphine
- naltrexone
- naphazoline
- naproxen
- naratriptan
- Vision blurred: infrequent
- nefazodone
- nefopam
- nelarabine
- nepafenac
- niacin
- Vision blurred: postmarketing
- nicardipine
- nifedipine
- Vision blurred: postmarketing
- nilotinib
- nitrazepam
- nitrite
- nitroglycerin
- norfloxacin
- nortriptyline
- ofloxacin
- Vision blurred: postmarketing
- olmesartan
- olopatadine
- olsalazine
- omeprazole
- Vision blurred: postmarketing, rare, uncommon
- ondansetron
- Vision blurred: postmarketing
- orlistat
- orphenadrine
- oxaprozin
- oxazepam
- oxcarbazepine
- Vision blurred: very rare, common, 1% - 4%
- oxybutynin
- Vision blurred: common, 2.3% - 9.6%
- oxymorphone
- paclitaxel
- paliperidone
- pantoprazole
- Vision blurred: postmarketing, uncommon
- paroxetine
- Vision blurred: postmarketing, common, 2% - 7.8%
- pazopanib
- pegaptanib
- pegaptanib sodium
- penicillin
- pentamidine
- pentazocine
- pentoxifylline
- Vision blurred: postmarketing, 2.3%
- perampanel
- perphenazine
- phendimetrazine
- phenelzine
- phenylephrine
- phenylpropanolamine
- pilocarpine
- pimozide
- Vision blurred: postmarketing
- piroxicam
- ponatinib
- posaconazole
- pralidoxime
- pramipexole
- Vision blurred: postmarketing, uncommon, common
- pravastatin
- Vision blurred: 1.5% - 3.4%
- prazosin
- prednisolone
- prednisolone acetate
- prednisone
- pregabalin
- prilocaine
- procaine
- prochlorperazine
- progesterone
- Vision blurred: postmarketing
- promethazine
- propafenone
- Vision blurred: postmarketing, 0.6% - 6%
- propantheline
- propericiazine
- propoxyphene
- protriptyline
- quetiapine
- Vision blurred: 1% - 5.1%
- quinidine
- rabeprazole
- ranitidine
- ranolazine
- regadenoson
- retigabine
- retinoic acid
- Vision blurred: postmarketing
- ribavirin
- Vision blurred: uncommon, common, 2%
- rimexolone
- risperidone
- ritonavir
- rivastigmine
- Vision blurred: infrequent
- rizatriptan
- Vision blurred: infrequent
- rofecoxib
- ropinirole
- Vision blurred: infrequent
- ropivacaine
- rufinamide
- salmon calcitonin acetate
- scopolamine
- sibutramine
- sildenafil
- simvastatin
- sitagliptin
- sodium
- sodium thiosulfate
- sofosbuvir
- solifenacin
- Vision blurred: 3.8% - 4.8%
- sotalol
- sulindac
- tacrolimus
- tadalafil
- Vision blurred: postmarketing
- tafluprost
- tamsulosin
- Vision blurred: postmarketing, 0.199% - 2.03%
- tapentadol
- telavancin
- telithromycin
- temazepam
- temozolomide
- Vision blurred: common, 0% - 9.03%
- terazosin
- Vision blurred: 0.6% - 1.6%
- terbinafine
- tetracaine
- thalidomide
- thiabendazole
- thiazide
- thioridazine
- thiotepa
- thiothixene
- tiaprofenic acid
- tibolone
- timolol
- Vision blurred: 4.1% - 6%
- tiotropium
- tizanidine
- tobramycin
- tolcapone
- topiramate
- Vision blurred: postmarketing, rare, 2% - 8.9%
- toremifene
- tramadol
- Vision blurred: postmarketing, rare, uncommon
- trametinib
- tranylcypromine
- travoprost
- Vision blurred: uncommon, 0.7% - 2%
- trazodone
- Vision blurred: 5.45% - 14.7%
- triamcinolone acetonide
- trifluoperazine
- trifluorothymidine
- trihexyphenidyl
- trimethobenzamide
- trimipramine
- tropicamide
- trospium chloride
- v 1784
- valdecoxib
- valganciclovir
- valproate
- valsartan
- vandetanib
- vardenafil
- varenicline
- Vision blurred: infrequent
- venlafaxine
- Vision blurred
- Difficulty focusing eyes
- verapamil
- Vision blurred: postmarketing
- verteporfin
- vigabatrin
- Vision blurred: common, 3% - 16%
- vilazodone
- vinflunine
- voriconazole
- Vision blurred: very common
- zalcitabine
- ziconotide
- Vision blurred: 12% - 14%
- ziprasidone
- zoledronic acid
- Vision blurred: postmarketing, uncommon
- zolpidem
- zopiclone
- zuclopenthixol
|
Drugs with this indication
|